Research / SYM / Fundamental state Inspectable configuration
State dimensions Filing 0001837240-24-000226 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.60% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-8.38% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
74.47% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
38.25% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
17.80% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-6.97% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
11.71% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
8.19% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Jun 25, 2022 0/4 normalized Level 3 Sep 24, 2022 0/7 normalized Level 3 Dec 24, 2022 0/7 normalized Level 3 Mar 25, 2023 0/7 normalized Level 3 Jun 24, 2023 0/8 normalized Level 3 Sep 30, 2023 0/8 normalized Level 3 Dec 30, 2023 0/8 normalized Level 3 Mar 30, 2024 0/8 normalized Level 3 Jun 29, 2024 4/8 normalized Level 3 Dec 30, 2023 0/8 normalized Amended as filed Mar 30, 2024 0/8 normalized Amended as filed Jun 29, 2024 4/8 normalized Amended as filed Sep 28, 2024 7/8 normalized Level 3 Dec 28, 2024 7/8 normalized Level 3 Mar 29, 2025 6/7 normalized Level 3 Jun 28, 2025 7/7 normalized Level 3 Sep 27, 2025 7/7 normalized Level 3 Dec 27, 2025 7/7 normalized Level 3 Mar 28, 2026 7/7 normalized Level 3 Jun 27, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 3.42%
Current 0.60%
Delta -2.82% Cash Generation Decreased
Previous 10.24%
Current -8.38%
Delta -18.62% Growth Increased
Previous 57.73%
Current 74.47%
Delta 16.73% Inventory Pressure Increased
Previous 26.86%
Current 38.25%
Delta 11.39% Margin Increased
Previous 13.70%
Current 17.80%
Delta 4.09% Profitability Decreased
Previous -5.12%
Current -6.97%
Delta -1.85% R And D Intensity Increased
Previous 9.09%
Current 11.71%
Delta 2.62% Sbc Intensity Increased
Previous 5.96%
Current 8.19%
Delta 2.22% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.